ACRVVSBJDX• 7 Days (Normalized)
ACRV vs BJDX (Acrivon Therapeutics Inc. vs Bluejay Diagnostics Inc.)
Showing Closing Date Range from Sep, 09 to Sep, 16, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ACRV Performance $1.7
-14.57%
Acrivon Therapeutics Inc.
Normalized Baseline0.00%
BJDX Performance $0.81
-19.5%
Bluejay Diagnostics Inc.
Normalized Baseline0.00%
Alpha Spread Margin ACRV LEADS
+4.93%
ACRV outperforming by 4.93%
ACRVBJDX
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ACRV BJDX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(6 dates)
| Date | ACRV Price | ACRV Gain (%) | BJDX Price | BJDX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 16, 2026 | $1.70 | -14.57% | $0.81 | -19.50% | +4.93% |
| Sep 15, 2026 | $1.83 | -8.04% | $0.85 | -16.04% | +8.00% |
| Sep 14, 2026 | $1.96 | -1.51% | $0.85 | -15.84% | +14.33% |
| Sep 11, 2026 | $2.00 | +0.50% | $0.90 | -11.19% | +11.69% |
| Sep 10, 2026 | $2.04 | +2.51% | $1.01 | +0.00% | +2.51% |
| Sep 09, 2026 | $1.99 | +0.00% | $1.01 | +0.00% | +0.00% |